JavaScript is disabled for your browser. Some features of this site may not work without it.
Get the latest COVID-19 technical guidance, scientific and policy briefs here.✕
    • العربية
    • 中文
    • English
    • français
    • русский
    • español
    • Deutsch
    • português
English
  • العربية
  • 中文
  • English
  • français
  • русский
  • español
  • Deutsch
  • português
  • Home
  • Contact
  • Help

Browse

All of IRISCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

Statistics

Most PopularBy Country

Related Links

WPRO IRISPAHO IRIS

THE PROTECTIVE EFFECT OF WHOOPING COUGH VACCINATION = PROTECTION CONFÉRÉE PAR LA VACCINATION ANTICOQUELUCHEUSE

Thumbnail
View/Open
WER5413_98-98.PDF (‎127.1Kb)‎
View Statistics
Show Statistical Information
Altmetrics
Share
  • CSV
  • Excel
  • BibTeX
  • RIS
Citation
World Health Organization. (‎1979)‎. THE PROTECTIVE EFFECT OF WHOOPING COUGH VACCINATION = PROTECTION CONFÉRÉE PAR LA VACCINATION ANTICOQUELUCHEUSE. Weekly Epidemiological Record = Relevé épidémiologique hebdomadaire, 54 (‎13)‎, 98. https://apps.who.int/iris/handle/10665/222419
Journal
Weekly Epidemiological Record = Relevé épidémiologique hebdomadaire, 54 (‎13)‎: 98
Language
English
français
Collections
  • Journal Articles
Metadata
Show full item record

Related items

Showing items related by title and subject

  • Thumbnail
    Protection-at-birth (‎PAB)‎ method, Tunisia : Monitoring tetanus toxoid coverage and avoiding missed opportunities for tetanus toxoid vaccination = Méthode de la «protection à la naissance», Tunisie : Surveillance de la couverture vaccinale antitétanique et mise à profit de toutes les occasions de vacciner 
    World Health Organization (‎2000)‎
  • Thumbnail
    Expanded Programme on Immunization : Estimating tetanus protection of women by serosurvey = Programme élargi de vaccination : Estimation de la protection des femmes contre le tétanos par enquête sérologique 
    World Health Organization (‎1996)‎
  • Thumbnail
    Sustainable development goals (‎SDGs)‎ : Goal 3. Target 3.b : Support the research and development of vaccines and medicines for the communicable and noncommunicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all [‎poster]‎ 
    World Health Organization. Regional Office for the Western Pacific (‎Manila : WHO Regional Office for the Western Pacific, 2016)‎

Show Statistical Information

View Item 
  • IRIS Home
  • 1. Headquarters
  • Journal Articles
  • View Item
  • IRIS Home
  • 1. Headquarters
  • Journal Articles
  • View Item

© WHO 2020